SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-020287
Filing Date
2022-07-26
Accepted
2022-07-25 20:53:12
Documents
13
Period of Report
2022-07-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43852
  Complete submission text file 0001493152-22-020287.txt   273768

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE foxw-20220720.xsd EX-101.SCH 4069
3 XBRL DEFINITION FILE foxw-20220720_def.xml EX-101.DEF 27681
4 XBRL LABEL FILE foxw-20220720_lab.xml EX-101.LAB 38437
5 XBRL PRESENTATION FILE foxw-20220720_pre.xml EX-101.PRE 26298
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7205
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39891 | Film No.: 221104709
SIC: 2834 Pharmaceutical Preparations